.1 ppm
Synthesis of Compound 1:
Compound 1 can be synthesized in an analogous way as 2 by using Re(CO) 5 Cl instead of Re(CO) 5 Br. 198.2, 197.9, 188.2, 174.3, 170.0, 156.6, 155.2, 153.4, 144.3, 141.2, 129.7, 129.5 128.1, 127.5, 125.7, 120.5, 66.1, 64.3, 54.2, 47.1, 30.7, 29.2, 23 .1 ppm Synthesis of peptide conjugates 3 and 4: Rhenium bioconjugates 3 and 4 were synthesized using standard SPPS methods using the FMOC protecting group strategy, as shown in Scheme S1. The completeness of each coupling reaction was monitored by the Kaiser Test. 1 FMOC-Leu-Wang resin (50 mg, substitution=0.8 mmol/g) was used for each synthesis. The resin was first swelled in DMF for 1 h.
The FMOC protecting group removal between each cycle was performed by 20-minute treatments with 20% piperidine in DMF followed by washing with DMF several times. Five equimolar equivalents of FMOC-Ile-OH, FMOC-Tyr(tBu)-OH, FMOC-Pro-OH and FMOC-Arg(Pbf)-OH along with 4.5 eq. of HBTU and HOBt as coupling reagents and 4-methylmorpholine (10 eq.) as base were used in this synthesis. The coupling process was performed for 2 hours followed by washing and performance of the Kaiser Test before starting each subsequent cycle. All reactions were performed on a mechanical shaker.
In some cases, excess unreacted amine termini remained present on the resins, which required that the coupling process be repeated. After completion of five cycles with the FMOC-protected amino acids, 5 eq. of the rhenium complex 1 were reacted overnight with use of HBTU/HOBt as the activator and 4-methylmorpholine in the same equimolar ratio as previously used. For compound 4, further coupling of 3 (on-resin) with 5(6)-carboxyfluorescein yields the fluorescently modified peptide. For both 3 and 4, the completed coupled resin turned orange after completion of the rhenium cycle. The resin was washed with DMF, moved to a clean round bottom flask and air-dried. DCM was added to the flask and the resin was allowed to swell (20-30 min). DCM was removed under vacuum and then the TFA (trifluoroacetic acid) cocktail cleavage method was started.
The TFA/water/triisopropylsilane (95:2.5:2.5) solution (7 mL) was added to dry peptide resin. 
Cell uptake experiments using Human Umbilical Vein Endothelial Cells (HUVECs)
Cell culture and imaging: Human umbilical vascular endothelial cells (HUVECs) were maintained in EBM2 medium with EGM2 Bullet supplements and 10% fetal bovine serum at 37 o C in a humidified 5% CO 2 environment. The cells were seeded on 24-well 0.1% gelatin coated plate in a concentration of 75,000 cells per well and incubated for 24 h prior to incubation with the rhenium compounds at different concentrations.
Incubations of compounds were carried out on adherent cells. Concentrated DMSO stock solutions of the compounds were diluted using cell culture medium to desired final concentrations. After incubations, the cells were washed three times with PBS (pH 7.4) and covered with medium for microscopic examination. The imaging experiments were carried out on an AMG EVOS All-in-one digital inverted microscope by using GFP Fluorescent light cube (excitation-470 nm and emission-525).
HUVECs ( Scheme S1. Solid phase peptide synthesis of compounds 3 and 4. i. FMOC-deprotection: 2 mL of piperidine (20% in DMF) was taken into the reaction column and the reaction was carried out for 2 x min with shaking. ii. Washing: The deprotection solution was pushed out of the reaction column into the waste container and the resin washed with 3 × 2 mL of DMF, 1 × 2 mL of MeOH, 1 × 2 mL of DCM and 1 × 2 mL of DMF. iii. Coupling: To the solution of the protected amino acid, HBTU and HOBt in DMF (approx. 1 mL) and 10x mole equivalents of N-methylmorpholine was added. The mixture was allowed to react for several minutes, added into the reaction column and the reaction column was shaken for 2 hours. iv. Washing: Repeat step ii. v. TFA Cleavage: TFA (95 %, 2.5% triisopropylsilane, 2.5% water) for 90 min. The TFA was removed by evaporation and the peptide was precipitated by addition of cold diethyl ether (10x excess). HPLC was performed on a GE Aktamicro equipped with UV900 detector using a Vydac RP-C18 column. Buffers system is 99.9% water+0.1% TFA (A) and 95%acetonitrile+5%water+0.1%TFA (B). After HPLC purification, the success of Re(CO) 3 -modified lysine chemistry as well as the purity improvement of the peptides were able to be confirmed by MALDI-TOF. 2 Both purified 3 and 4 were used in cell experiment.
